UBE2L6 and Parkinson disease: PD was marked by prominent dysregulation of ubiquitin pathway components, including HGS, ARRDC3, UBE2L6 and UBE2C, consistent with the well-established role of impaired protein degradation in PD pathogenesis55,56.